BlackRock’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121M | Sell |
|
|||||
|
2025
Q1 | $158M | Sell |
|
|||||
|
2024
Q4 | $136M | Sell |
|
|||||
|
2024
Q3 | $200M | Sell |
|
|||||
|
2024
Q2 | $137M | Buy |
|
|||||
|
2024
Q1 | $148M | Buy |
|
|||||
|
2023
Q4 | $154M | Buy |
|
|||||
|
2023
Q3 | $145M | Sell |
|
|||||
|
2023
Q2 | $155M | Buy |
|
|||||
|
2023
Q1 | $152M | Buy |
|
|||||
|
2022
Q4 | $155M | Sell |
|
|||||
|
2022
Q3 | $376M | Sell |
|
|||||
|
2022
Q2 | $463M | Buy |
|
|||||
|
2022
Q1 | $509M | Buy |
|
|||||
|
2021
Q4 | $705M | Sell |
|
|||||
|
2021
Q3 | $955M | Buy |
|
|||||
|
2021
Q2 | $868M | Sell |
|
|||||
|
2021
Q1 | $908M | Buy |
|
|||||
|
2020
Q4 | $668M | Buy |
|
|||||
|
2020
Q3 | $643M | Buy |
|
|||||
|
2020
Q2 | $411M | Buy |
|
|||||
|
2020
Q1 | $245M | Buy |
|
|||||
|
2019
Q4 | $325M | Sell |
|
|||||
|
2019
Q3 | $244M | Sell |
|
|||||
|
2019
Q2 | $249M | Buy |
|
|||||
|
2019
Q1 | $254M | Buy |
|
|||||
|
2018
Q4 | $263M | Buy |
|
|||||
|
2018
Q3 | $81.9M | Buy |
|
|||||
|
2018
Q2 | $66.9M | Buy |
|
|||||
|
2018
Q1 | $59.4M | Sell |
|
|||||
|
2017
Q4 | $34.9M | Buy |
|
|||||
|
2017
Q3 | $35.6M | Buy |
|
|||||
|
2017
Q2 | $13.2M | Buy |
|
|||||
|
2017
Q1 | $9.69M | Buy |
|
|||||
|
2016
Q4 | $128K | Buy |
|
|||||
|
2016
Q3 | $113K | Sell |
|
|||||
|
2016
Q2 | $114K | Buy |
|
|||||
|
2016
Q1 | $3K | Buy |
|